OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Outset Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.80−0.14 (-3.55%)
Close on Oct 19, 2026
- Market cap
- $70.75K
- P/E (TTM)
- –
- Dividend yield
- –
Outset Medical, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | $21.91M | $18.55M | $19.87M | $20.56M | $23.08M | $21.29M | $21.01M | $20.31M | $19.24M | $20.43M | $22.90M | $23.53M | 69.3% | -5.1% |
| Consumables Product | $12.42M | $13.18M | $13.50M | $12.22M | $14.15M | $14.20M | $15.25M | $12.60M | $12.08M | $11.22M | $12.62M | $11.03M | 39.3% | -12.2% |
| Service and Other Revenue | $9.73M | $9.31M | $9.00M | $8.87M | $8.34M | $8.46M | $8.46M | $8.36M | $8.15M | $7.74M | $7.61M | $6.83M | 30.7% | +16.7% |
| Consoles Product | $9.49M | $5.37M | $6.37M | $8.34M | $8.93M | $7.09M | $5.75M | $7.71M | $7.16M | $9.21M | $10.28M | $12.51M | 30.0% | +6.2% |
By region
From the segment and revenue-disaggregation notes of Outset Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.